Page last updated: 2024-10-26

valproic acid and Anaplastic Oligodendroglioma

valproic acid has been researched along with Anaplastic Oligodendroglioma in 2 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Habets, JGV1
Leentjens, AFG1
Schijns, OEMG1
Bianchi, MG1
Franchi-Gazzola, R1
Reia, L1
Allegri, M1
Uggeri, J1
Chiu, M1
Sala, R1
Bussolati, O1

Other Studies

2 other studies available for valproic acid and Anaplastic Oligodendroglioma

ArticleYear
Serious and reversible levetiracetam-induced psychiatric symptoms after resection of frontal low-grade glioma: two case histories.
    British journal of neurosurgery, 2017, Volume: 31, Issue:4

    Topics: Anticonvulsants; Brain Neoplasms; Craniotomy; Epilepsy; Frontal Lobe; Humans; Levetiracetam; Magneti

2017
Valproic acid induces the glutamate transporter excitatory amino acid transporter-3 in human oligodendroglioma cells.
    Neuroscience, 2012, Dec-27, Volume: 227

    Topics: 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase; Anticonvulsants; Aspartic Acid; Cell Line, Tumor; Enzy

2012